[DOI] [PMC free article] [PubMed] [Google Scholar] 196.Jerlhag E
p 0.05 was taken as a criterion for a statistically significant difference
GLP-1 receptor agonists, like GLP-1, binds to and activates GLP-1 receptors in the body
The injectable form of semaglutide has also been approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition (like high blood pressure, type 2 diabetes, or high cholesterol), under the brand name Wegovy
FIGURE 2 3.3 Metabolic commonalities and differences between the two pneumonia models To compare metabolic features between the models, Venn analysis was conducted to compare the metabolic features between the two pneumonia models, revealing 17 shared differentially abundant metabolites with consistent directional changes in both models (Figures 3A, B)
London: Printed for the Sydenham Society, 184447